We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Human Cell Lines for Use in Research

By Biotechdaily staff writers
Posted on 06 Nov 2003
Three human cells lines, derived from either the pituitary or pancreas gland, provide novel cells that can be used in basic research in diabetes, pancreatic cancer, and endocrinology of the pituitary gland.

Two of the cell lines are immortalized lines that were generated by the patented technology of Vitro Diagnostics, Inc., (Aurora, CO, USA), which launched the cell lines. More...
This technology is based on the expression of certain immortalizing genes. Another human pancreatic cell line is nonimmortalized and may be used to compare with a similar immortalized line to determine specific properties unique to the latter. The cell lines are extensively tested to ensure sterility and the absence of common cell contaminants such as viruses, fungi, and mycoplasma. The line of cells is called Vitrocell.

In addition to basic research, Vitro Diagnostics believes the lines may be used in the production of biotherapeutic products such as humanized antibodies, recombinant human proteins, and vaccines. The company also offers a series of complementary products and procedures to ensure the successful establishment and growth of these cells, such as cell culture media and specific reagents needed for long-timer survival and cryopreservation.

"Together with our strong technical support, we anticipate that our customers will be able to investigate the use of these cells in a variety of novel applications, including the production of biotherapeutic agents,” said Dr. Jim Musick, president and CEO of Vitro Diagnostics.




Related Links:
Vitro Diagnostics

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Automated Urinalysis Solution
UN-9000
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.